BPC-157 is not FDA-approved for any medical condition, but it is legally available through licensed 503A compounding pharmacies with a provider prescription
Tesamorelin increases endogenous GH and IGF-1 levels, providing broader metabolic effects but also potential for glucose elevation and insulin resistance
By completing your purchase, you acknowledge that SLU-PP-332 is an investigational material not approved for general medical or therapeutic use by any regulatory authority
Capacity: 10 peptide vials + 1 dedicated bac water slot
Their products are sold for in vitro research, preclinical studies, and scientific investigation
BPC 157 was given per-orally, in drinking water (10 g/kg, 10 ng/kg, i.e., 0.16 g/ml, 0.16 ng/ml, and 12 ml/rat/day) till sacrifice, or alternatively, 10 g/kg and 10 ng/kg intraperitoneally